Primecap Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $867M | Sell |
15,772,173
-2,001,108
| -11% | -$110M | 0.69% | 44 |
|
2025
Q1 | $1.26B | Sell |
17,773,281
-415,890
| -2% | -$29.4M | 1.04% | 29 |
|
2024
Q4 | $1.2B | Sell |
18,189,171
-678,264
| -4% | -$44.6M | 0.93% | 35 |
|
2024
Q3 | $1.33B | Buy |
18,867,435
+77,350
| +0.4% | +$5.44M | 0.98% | 30 |
|
2024
Q2 | $1.55B | Buy |
18,790,085
+76,190
| +0.4% | +$6.27M | 1.12% | 23 |
|
2024
Q1 | $1.63B | Buy |
18,713,895
+299,521
| +2% | +$26.2M | 1.22% | 19 |
|
2023
Q4 | $1.78B | Buy |
18,414,374
+7,835
| +0% | +$755K | 1.41% | 18 |
|
2023
Q3 | $1.63B | Buy |
18,406,539
+22,920
| +0.1% | +$2.03M | 1.37% | 18 |
|
2023
Q2 | $1.59B | Buy |
18,383,619
+140,190
| +0.8% | +$12.2M | 1.33% | 19 |
|
2023
Q1 | $1.77B | Buy |
18,243,429
+662,570
| +4% | +$64.4M | 1.55% | 17 |
|
2022
Q4 | $1.82B | Sell |
17,580,859
-44,646
| -0.3% | -$4.62M | 1.67% | 15 |
|
2022
Q3 | $1.49B | Sell |
17,625,505
-52,980
| -0.3% | -$4.49M | 1.45% | 18 |
|
2022
Q2 | $1.47B | Sell |
17,678,485
-100,985
| -0.6% | -$8.37M | 1.31% | 22 |
|
2022
Q1 | $1.37B | Sell |
17,779,470
-25,310
| -0.1% | -$1.95M | 1.03% | 27 |
|
2021
Q4 | $1.57B | Sell |
17,804,780
-132,550
| -0.7% | -$11.7M | 1.09% | 26 |
|
2021
Q3 | $1.39B | Sell |
17,937,330
-15,736
| -0.1% | -$1.22M | 0.98% | 27 |
|
2021
Q2 | $1.5B | Sell |
17,953,066
-204,728
| -1% | -$17.1M | 1.01% | 27 |
|
2021
Q1 | $1.37B | Buy |
18,157,794
+9,833
| +0.1% | +$742K | 0.96% | 31 |
|
2020
Q4 | $1.59B | Sell |
18,147,961
-43,580
| -0.2% | -$3.82M | 1.18% | 24 |
|
2020
Q3 | $1.38B | Buy |
18,191,541
+307,570
| +2% | +$23.4M | 1.14% | 22 |
|
2020
Q2 | $2.21B | Buy |
17,883,971
+74,204
| +0.4% | +$9.15M | 1.89% | 13 |
|
2020
Q1 | $1.5B | Buy |
17,809,767
+1,480,447
| +9% | +$125M | 1.48% | 18 |
|
2019
Q4 | $1.38B | Buy |
16,329,320
+1,167,246
| +8% | +$98.7M | 1% | 29 |
|
2019
Q3 | $1.02B | Buy |
15,162,074
+878,321
| +6% | +$59.2M | 0.82% | 38 |
|
2019
Q2 | $1.22B | Buy |
14,283,753
+92,880
| +0.7% | +$7.96M | 0.9% | 34 |
|
2019
Q1 | $1.26B | Buy |
14,190,873
+5,700
| +0% | +$506K | 0.93% | 33 |
|
2018
Q4 | $1.21B | Sell |
14,185,173
-23,312
| -0.2% | -$1.99M | 0.98% | 30 |
|
2018
Q3 | $1.38B | Sell |
14,208,485
-32,304
| -0.2% | -$3.13M | 0.93% | 33 |
|
2018
Q2 | $1.34B | Buy |
14,240,789
+474,250
| +3% | +$44.7M | 0.99% | 30 |
|
2018
Q1 | $1.12B | Buy |
13,766,539
+3,521,244
| +34% | +$285M | 0.84% | 37 |
|
2017
Q4 | $914M | Buy |
10,245,295
+606,651
| +6% | +$54.1M | 0.7% | 42 |
|
2017
Q3 | $897M | Buy |
9,638,644
+328,420
| +4% | +$30.6M | 0.74% | 38 |
|
2017
Q2 | $846M | Buy |
9,310,224
+597,956
| +7% | +$54.3M | 0.73% | 42 |
|
2017
Q1 | $765M | Buy |
8,712,268
+826,320
| +10% | +$72.5M | 0.69% | 45 |
|
2016
Q4 | $653M | Buy |
7,885,948
+777,819
| +11% | +$64.4M | 0.64% | 46 |
|
2016
Q3 | $658M | Sell |
7,108,129
-211,190
| -3% | -$19.5M | 0.66% | 46 |
|
2016
Q2 | $569M | Sell |
7,319,319
-31,050
| -0.4% | -$2.42M | 0.61% | 48 |
|
2016
Q1 | $606M | Buy |
7,350,369
+19,680
| +0.3% | +$1.62M | 0.63% | 50 |
|
2015
Q4 | $768M | Sell |
7,330,689
-34,350
| -0.5% | -$3.6M | 0.79% | 39 |
|
2015
Q3 | $776M | Sell |
7,365,039
-627,710
| -8% | -$66.1M | 0.86% | 31 |
|
2015
Q2 | $1.09B | Sell |
7,992,749
-32,259
| -0.4% | -$4.41M | 1.08% | 23 |
|
2015
Q1 | $1B | Buy |
8,025,008
+8,490
| +0.1% | +$1.06M | 0.98% | 27 |
|
2014
Q4 | $725M | Sell |
8,016,518
-27,400
| -0.3% | -$2.48M | 0.73% | 39 |
|
2014
Q3 | $580M | Sell |
8,043,918
-20,301
| -0.3% | -$1.46M | 0.62% | 44 |
|
2014
Q2 | $502M | Sell |
8,064,219
-99,500
| -1% | -$6.19M | 0.55% | 50 |
|
2014
Q1 | $557M | Buy |
8,163,719
+603,590
| +8% | +$41.2M | 0.63% | 44 |
|
2013
Q4 | $532M | Sell |
7,560,129
-46,800
| -0.6% | -$3.29M | 0.64% | 38 |
|
2013
Q3 | $549M | Sell |
7,606,929
-77,400
| -1% | -$5.59M | 0.72% | 36 |
|
2013
Q2 | $429M | Buy |
+7,684,329
| New | +$429M | 0.61% | 46 |
|